Display Settings:

Format

Send to:

Choose Destination
    Addict Biol. 2009 Apr;14(2):130-43.

    Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.

    Source

    Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, USA.

    Abstract

    Dysregulation of the stress-related corticotropin-releasing factor (CRF) system has been implicated in the development of drug dependence. The present study examined the effects of administering CRF type 1 (CRF(1)) receptor antagonists on heroin self-administration in animals allowed short (1 hour) or long (8-12 hours) access to intravenous heroin self-administration sessions. The nonpeptide CRF(1) antagonists MJL-1-109-2 (1 hour versus 8 hours access) or R121919 (1 hour versus 12 hours access) were systemically injected in both short- and long-access rats. MJL-1-109-2 (10 mg/kg) and R121919 (10 and 20 mg/kg) reduced heroin self-administration in long-access animals without altering heroin intake in short-access animals. Both MJL-1-109-2 and R121919 decreased first-hour intravenous heroin self-administration selectively in long-access rats, with R121919 decreasing cumulative heroin intake across the 12-hour session. The results demonstrate that blockade of the CRF-CRF(1) receptor system attenuates the increased heroin intake of rats with extended access to the drug.

    PMID:
    19291009
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2748834
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Figure 1
    Figure 5
    Figure 4
    Figure 2
    Figure 3
    Figure 6

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk